List of Tables
Table 1. Global Sexually Transmitted Diseases Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Sexually Transmitted Diseases Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Sexually Transmitted Diseases Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Sexually Transmitted Diseases Drug Sales (Tons) of Key Manufacturers (2019-2024)
Table 5. Global Sexually Transmitted Diseases Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Sexually Transmitted Diseases Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Sexually Transmitted Diseases Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Sexually Transmitted Diseases Drug Average Price (US$/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Sexually Transmitted Diseases Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Sexually Transmitted Diseases Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Sexually Transmitted Diseases Drug, Product Type & Application
Table 12. Global Key Manufacturers of Sexually Transmitted Diseases Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sexually Transmitted Diseases Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Sexually Transmitted Diseases Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Sexually Transmitted Diseases Drug Sales by Region (2019-2024) & (Tons)
Table 18. Global Sexually Transmitted Diseases Drug Sales Market Share by Region (2019-2024)
Table 19. Global Sexually Transmitted Diseases Drug Sales by Region (2025-2030) & (Tons)
Table 20. Global Sexually Transmitted Diseases Drug Sales Market Share by Region (2025-2030)
Table 21. Global Sexually Transmitted Diseases Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Sexually Transmitted Diseases Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Sexually Transmitted Diseases Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Sexually Transmitted Diseases Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Sexually Transmitted Diseases Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Sexually Transmitted Diseases Drug Sales by Country (2019-2024) & (Tons)
Table 27. North America Sexually Transmitted Diseases Drug Sales by Country (2025-2030) & (Tons)
Table 28. North America Sexually Transmitted Diseases Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Sexually Transmitted Diseases Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Sexually Transmitted Diseases Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Sexually Transmitted Diseases Drug Sales by Country (2019-2024) & (Tons)
Table 32. Europe Sexually Transmitted Diseases Drug Sales by Country (2025-2030) & (Tons)
Table 33. Europe Sexually Transmitted Diseases Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Sexually Transmitted Diseases Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Sexually Transmitted Diseases Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Sexually Transmitted Diseases Drug Sales by Region (2019-2024) & (Tons)
Table 37. Asia Pacific Sexually Transmitted Diseases Drug Sales by Region (2025-2030) & (Tons)
Table 38. Asia Pacific Sexually Transmitted Diseases Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Sexually Transmitted Diseases Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Sexually Transmitted Diseases Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Sexually Transmitted Diseases Drug Sales by Country (2019-2024) & (Tons)
Table 42. Latin America Sexually Transmitted Diseases Drug Sales by Country (2025-2030) & (Tons)
Table 43. Latin America Sexually Transmitted Diseases Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Sexually Transmitted Diseases Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Sexually Transmitted Diseases Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Sexually Transmitted Diseases Drug Sales by Country (2019-2024) & (Tons)
Table 47. Middle East & Africa Sexually Transmitted Diseases Drug Sales by Country (2025-2030) & (Tons)
Table 48. Middle East & Africa Sexually Transmitted Diseases Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Sexually Transmitted Diseases Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Sexually Transmitted Diseases Drug Sales (Tons) by Type (2019-2024)
Table 51. Global Sexually Transmitted Diseases Drug Sales (Tons) by Type (2025-2030)
Table 52. Global Sexually Transmitted Diseases Drug Sales Market Share by Type (2019-2024)
Table 53. Global Sexually Transmitted Diseases Drug Sales Market Share by Type (2025-2030)
Table 54. Global Sexually Transmitted Diseases Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Sexually Transmitted Diseases Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Sexually Transmitted Diseases Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Sexually Transmitted Diseases Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Sexually Transmitted Diseases Drug Price (US$/Kg) by Type (2019-2024)
Table 59. Global Sexually Transmitted Diseases Drug Price (US$/Kg) by Type (2025-2030)
Table 60. Global Sexually Transmitted Diseases Drug Sales (Tons) by Application (2019-2024)
Table 61. Global Sexually Transmitted Diseases Drug Sales (Tons) by Application (2025-2030)
Table 62. Global Sexually Transmitted Diseases Drug Sales Market Share by Application (2019-2024)
Table 63. Global Sexually Transmitted Diseases Drug Sales Market Share by Application (2025-2030)
Table 64. Global Sexually Transmitted Diseases Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Sexually Transmitted Diseases Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Sexually Transmitted Diseases Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Sexually Transmitted Diseases Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Sexually Transmitted Diseases Drug Price (US$/Kg) by Application (2019-2024)
Table 69. Global Sexually Transmitted Diseases Drug Price (US$/Kg) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Sexually Transmitted Diseases Drug Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 73. Pfizer Sexually Transmitted Diseases Drug Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Merck & Co. Corporation Information
Table 76. Merck & Co. Description and Business Overview
Table 77. Merck & Co. Sexually Transmitted Diseases Drug Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 78. Merck & Co. Sexually Transmitted Diseases Drug Product
Table 79. Merck & Co. Recent Developments/Updates
Table 80. Gilead Sciences Corporation Information
Table 81. Gilead Sciences Description and Business Overview
Table 82. Gilead Sciences Sexually Transmitted Diseases Drug Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 83. Gilead Sciences Sexually Transmitted Diseases Drug Product
Table 84. Gilead Sciences Recent Developments/Updates
Table 85. Hoffmann La Roche Corporation Information
Table 86. Hoffmann La Roche Description and Business Overview
Table 87. Hoffmann La Roche Sexually Transmitted Diseases Drug Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 88. Hoffmann La Roche Sexually Transmitted Diseases Drug Product
Table 89. Hoffmann La Roche Recent Developments/Updates
Table 90. Bayer Healthcare Corporation Information
Table 91. Bayer Healthcare Description and Business Overview
Table 92. Bayer Healthcare Sexually Transmitted Diseases Drug Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 93. Bayer Healthcare Sexually Transmitted Diseases Drug Product
Table 94. Bayer Healthcare Recent Developments/Updates
Table 95. Eli Lilly Corporation Information
Table 96. Eli Lilly Description and Business Overview
Table 97. Eli Lilly Sexually Transmitted Diseases Drug Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 98. Eli Lilly Sexually Transmitted Diseases Drug Product
Table 99. Eli Lilly Recent Developments/Updates
Table 100. Bristol Myers Squibb Corporation Information
Table 101. Bristol Myers Squibb Description and Business Overview
Table 102. Bristol Myers Squibb Sexually Transmitted Diseases Drug Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 103. Bristol Myers Squibb Sexually Transmitted Diseases Drug Product
Table 104. Bristol Myers Squibb Recent Developments/Updates
Table 105. Johnson & Johnson Corporation Information
Table 106. Johnson & Johnson Description and Business Overview
Table 107. Johnson & Johnson Sexually Transmitted Diseases Drug Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 108. Johnson & Johnson Sexually Transmitted Diseases Drug Product
Table 109. Johnson & Johnson Recent Developments/Updates
Table 110. GlaxoSmithKline Plc Corporation Information
Table 111. GlaxoSmithKline Plc Description and Business Overview
Table 112. GlaxoSmithKline Plc Sexually Transmitted Diseases Drug Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 113. GlaxoSmithKline Plc Sexually Transmitted Diseases Drug Product
Table 114. GlaxoSmithKline Plc Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Sexually Transmitted Diseases Drug Distributors List
Table 118. Sexually Transmitted Diseases Drug Customers List
Table 119. Sexually Transmitted Diseases Drug Market Trends
Table 120. Sexually Transmitted Diseases Drug Market Drivers
Table 121. Sexually Transmitted Diseases Drug Market Challenges
Table 122. Sexually Transmitted Diseases Drug Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Sexually Transmitted Diseases Drug
Figure 2. Global Sexually Transmitted Diseases Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Sexually Transmitted Diseases Drug Market Share by Type in 2023 & 2030
Figure 4. Antiviral / Antiretrovirals Product Picture
Figure 5. Antibiotics Product Picture
Figure 6. Vaccines Product Picture
Figure 7. Global Sexually Transmitted Diseases Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Sexually Transmitted Diseases Drug Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Cinic
Figure 11. Other
Figure 12. Global Sexually Transmitted Diseases Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Sexually Transmitted Diseases Drug Market Size (2019-2030) & (US$ Million)
Figure 14. Global Sexually Transmitted Diseases Drug Sales (2019-2030) & (Tons)
Figure 15. Global Sexually Transmitted Diseases Drug Average Price (US$/Kg) & (2019-2030)
Figure 16. Sexually Transmitted Diseases Drug Report Years Considered
Figure 17. Sexually Transmitted Diseases Drug Sales Share by Manufacturers in 2023
Figure 18. Global Sexually Transmitted Diseases Drug Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Sexually Transmitted Diseases Drug Players: Market Share by Revenue in 2023
Figure 20. Sexually Transmitted Diseases Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Sexually Transmitted Diseases Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Sexually Transmitted Diseases Drug Sales Market Share by Country (2019-2030)
Figure 23. North America Sexually Transmitted Diseases Drug Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Sexually Transmitted Diseases Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Sexually Transmitted Diseases Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Sexually Transmitted Diseases Drug Sales Market Share by Country (2019-2030)
Figure 27. Europe Sexually Transmitted Diseases Drug Revenue Market Share by Country (2019-2030)
Figure 28. Germany Sexually Transmitted Diseases Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Sexually Transmitted Diseases Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Sexually Transmitted Diseases Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Sexually Transmitted Diseases Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Sexually Transmitted Diseases Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Sexually Transmitted Diseases Drug Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Sexually Transmitted Diseases Drug Revenue Market Share by Region (2019-2030)
Figure 35. China Sexually Transmitted Diseases Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Sexually Transmitted Diseases Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Sexually Transmitted Diseases Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Sexually Transmitted Diseases Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Sexually Transmitted Diseases Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Sexually Transmitted Diseases Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Sexually Transmitted Diseases Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Sexually Transmitted Diseases Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Sexually Transmitted Diseases Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Sexually Transmitted Diseases Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Sexually Transmitted Diseases Drug Sales Market Share by Country (2019-2030)
Figure 46. Latin America Sexually Transmitted Diseases Drug Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Sexually Transmitted Diseases Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Sexually Transmitted Diseases Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Sexually Transmitted Diseases Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Sexually Transmitted Diseases Drug Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Sexually Transmitted Diseases Drug Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Sexually Transmitted Diseases Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Sexually Transmitted Diseases Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Sexually Transmitted Diseases Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Sexually Transmitted Diseases Drug by Type (2019-2030)
Figure 56. Global Revenue Market Share of Sexually Transmitted Diseases Drug by Type (2019-2030)
Figure 57. Global Sexually Transmitted Diseases Drug Price (US$/Kg) by Type (2019-2030)
Figure 58. Global Sales Market Share of Sexually Transmitted Diseases Drug by Application (2019-2030)
Figure 59. Global Revenue Market Share of Sexually Transmitted Diseases Drug by Application (2019-2030)
Figure 60. Global Sexually Transmitted Diseases Drug Price (US$/Kg) by Application (2019-2030)
Figure 61. Sexually Transmitted Diseases Drug Value Chain
Figure 62. Sexually Transmitted Diseases Drug Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed